My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Tricida, Inc. - Common Stock (NQ:TCDA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 23, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tricida, Inc. - Common Stock

< Previous 1 2 3 4 Next >

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Tricida, Inc. (TCDA) and Encourages Long-Term TCDA Stockholders to Contact the Firm

October 13, 2022

From Kaskela Law LLC

Via Business Wire

Coinbase Global And 3 Other Stocks Insiders Are Buying ↗

October 07, 2022

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

$17 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying ↗

October 04, 2022

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Tricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022

October 03, 2022

From Tricida, Inc.

Via Business Wire

Analyst Ratings for Tricida ↗

May 24, 2022

Within the last quarter, Tricida (NASDAQ:TCDA) has observed the following analyst ratings:

Via Benzinga

Read Why Did Tricida Stop VALOR-CKD Renal Outcomes Trial Early ↗

May 19, 2022

Via Benzinga

Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗

September 30, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Over $352 Million Bet On Occidental Petroleum? 3 Stocks Insiders Are Buying ↗

September 29, 2022

Although US stocks closed higher on Wednesday, there were a few notable insider trades.

Via Benzinga

TRICIDA INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tricida, Inc. - TCDA

September 23, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 20, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Around $8 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying ↗

September 08, 2022

Although US stocks closed higher on Wednesday, there were a few notable insider trades.

Via Benzinga

Tricida to Present at the H.C. Wainwright 24th Annual Global Investment Conference

September 06, 2022

From Tricida, Inc.

Via Business Wire

15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome ↗

August 30, 2022

Not all shares are slowing down alongside the industry group.

Via Investor's Business Daily

TRICIDA INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tricida, Inc. - TCDA

August 26, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗

August 09, 2022

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....

Via Benzinga

Tricida Announces Second Quarter 2022 Financial Results

August 08, 2022

From Tricida, Inc.

Via Business Wire

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗

July 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

$1.4 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying ↗

July 21, 2022

Although US stocks closed higher on Wednesday, there were a few notable insider trades.

Via Benzinga

$7.6 Million Bet On GMS? 3 Stocks Insiders are Buying ↗

June 27, 2022

Although the US stocks closed sharply higher on Friday, there were a few notable insider trades.

Via Benzinga

Insiders Buy More Than $15M Of 3 Stocks ↗

June 10, 2022

Although the Dow Jones dropped by more than 600 points on Thursday, there were a few notable insider trades.

Via Benzinga

Earnings Scheduled For August 8, 2022 ↗

August 08, 2022

Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.

Via Benzinga

Tricida: Q1 Earnings Insights ↗

May 10, 2022

Tricida (NASDAQ:TCDA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Tricida beat estimated earnings by...

Via Benzinga

Tricida's Earnings: A Preview ↗

May 09, 2022

Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report...

Via Benzinga

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

Earnings Scheduled For May 10, 2022 ↗

May 10, 2022

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022 ↗

April 13, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

Earnings Preview: Tricida ↗

March 28, 2022

Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition